{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T20:10:07Z","timestamp":1785787807568,"version":"3.56.0"},"reference-count":208,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["IIRP-23\/4760"],"award-info":[{"award-number":["IIRP-23\/4760"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["DST\/WISE-PhD\/LS\/2023\/44"],"award-info":[{"award-number":["DST\/WISE-PhD\/LS\/2023\/44"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001412","name":"Council of Scientific and Industrial Research, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Colloids and Surfaces B: Biointerfaces"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.colsurfb.2026.115798","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T16:08:50Z","timestamp":1778602130000},"page":"115798","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Emerging trends in implication of nanocarriers in repolarization of tumor associated macrophages for improved triple negative breast cancer therapy"],"prefix":"10.1016","volume":"266","author":[{"given":"Nagma","family":"Banjare","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manisha","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhradeep","family":"Kuiry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3072-7000","authenticated-orcid":false,"given":"Prem N.","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.colsurfb.2026.115798_bib1","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s12032-017-1071-6","article-title":"Immunotherapy in triple-negative breast cancer","volume":"35","author":"Katz","year":"2018","journal-title":"Med. Oncol."},{"issue":"1","key":"10.1016\/j.colsurfb.2026.115798_bib2","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13058-020-01296-5","article-title":"Triple-negative breast cancer molecular subtyping and treatment progress","volume":"22","author":"Yin","year":"2020","journal-title":"Breast Cancer Res"},{"issue":"41","key":"10.1016\/j.colsurfb.2026.115798_bib3","article-title":"Nanotherapeutics in women's health emerging nanotechnologies for triple-negative breast cancer treatment","volume":"20","author":"Torres Quintas","year":"2024","journal-title":"Small"},{"key":"10.1016\/j.colsurfb.2026.115798_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccr.2023.215507","article-title":"Beyond cisplatin: new frontiers in metallodrugs for hard-to-treat triple negative breast cancer","volume":"499","author":"Muhammad","year":"2024","journal-title":"Coord. Chem. Rev."},{"issue":"35","key":"10.1016\/j.colsurfb.2026.115798_bib5","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2205456119","article-title":"Metastatic triple negative breast cancer adapts its metabolism to destination tissues while retaining key metabolic signatures","volume":"119","author":"Roshanzamir","year":"2022","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"10.1016\/j.colsurfb.2026.115798_bib6","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s13045-022-01341-0","article-title":"Recent advances in therapeutic strategies for triple-negative breast cancer","volume":"15","author":"Li","year":"2022","journal-title":"J. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.colsurfb.2026.115798_bib7","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/s41392-021-00572-w","article-title":"Small molecules in targeted cancer therapy: advances, challenges, and future perspectives","volume":"6","author":"Zhong","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"issue":"12","key":"10.1016\/j.colsurfb.2026.115798_bib8","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.3390\/pharmaceutics13122003","article-title":"Immunotherapy for triple-negative breast cancer","volume":"13","author":"Cao","year":"2021","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.colsurfb.2026.115798_bib9","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S1470-2045(19)30689-8","article-title":"Atezolizumab plus nab-paclitaxel as first-line treatment for unresectable, locally advanced or metastatic triple-negative breast cancer (IMpassion130): updated efficacy results from a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"21","author":"Schmid","year":"2020","journal-title":"Lancet Oncol."},{"issue":"1","key":"10.1016\/j.colsurfb.2026.115798_bib10","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41523-024-00618-6","article-title":"High B7-H3 expression with low PD-L1 expression identifies armored-cold tumors in triple-negative breast cancer","volume":"10","author":"Mei","year":"2024","journal-title":"NPJ Breast Cancer"},{"issue":"1","key":"10.1016\/j.colsurfb.2026.115798_bib11","doi-asserted-by":"crossref","first-page":"6579","DOI":"10.1038\/s41467-022-34000-6","article-title":"MYC promotes immune-suppression in triple-negative breast cancer via inhibition of interferon signaling","volume":"13","author":"Zimmerli","year":"2022","journal-title":"Nat. Commun."},{"issue":"20","key":"10.1016\/j.colsurfb.2026.115798_bib12","doi-asserted-by":"crossref","first-page":"15332","DOI":"10.3390\/ijms242015332","article-title":"Unveiling the immune microenvironment\u2019s role in breast cancer: a glimpse into promising frontiers","volume":"24","author":"Kotsifaki","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.colsurfb.2026.115798_bib13","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/nm.3394","article-title":"Microenvironmental regulation of tumor progression and metastasis","volume":"19","author":"Quail","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.colsurfb.2026.115798_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/CMAR.S316700","article-title":"The characteristics of tumor microenvironment in triple negative breast cancer","author":"Fan","year":"2022","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.colsurfb.2026.115798_bib15","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/j.jconrel.2024.12.078","article-title":"Autophagy inhibition alleviates tumor desmoplasia and improves the efficacy of locally and systemically administered liposomal doxorubicin","volume":"378","author":"Sandha","year":"2025","journal-title":"J. Control. Release"},{"issue":"6","key":"10.1016\/j.colsurfb.2026.115798_bib16","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1021\/acs.molpharmaceut.2c01081","article-title":"Antifibrotic agent mediated tumor microenvironment modulation and improved nanomedicine delivery in solid tumor","volume":"20","author":"Sandha","year":"2023","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.colsurfb.2026.115798_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2022.106238","article-title":"Implication of methylselenocysteine in combination chemotherapy with gemcitabine for improved anticancer efficacy","volume":"176","author":"Behera","year":"2022","journal-title":"Eur. J. Pharm. Sci."},{"issue":"13","key":"10.1016\/j.colsurfb.2026.115798_bib18","doi-asserted-by":"crossref","first-page":"3357","DOI":"10.3390\/cancers13133357","article-title":"Tumor microenvironment: key players in triple negative breast cancer immunomodulation","volume":"13","author":"Zheng","year":"2021","journal-title":"Cancers"},{"issue":"9","key":"10.1016\/j.colsurfb.2026.115798_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2020.153085","article-title":"The role of tumor-associated macrophages in the development, metastasis and treatment of breast cancer","volume":"216","author":"Lu","year":"2020","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.colsurfb.2026.115798_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2019.119559","article-title":"Dual inhibition of CSF1R and MAPK pathways using supramolecular nanoparticles enhances macrophage immunotherapy","volume":"227","author":"Ramesh","year":"2020","journal-title":"Biomater"},{"issue":"2","key":"10.1016\/j.colsurfb.2026.115798_bib21","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3892\/ol.2021.13171","article-title":"Role of the tumor immune microenvironment in tumor immunotherapy","volume":"23","author":"Zhou","year":"2022","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.colsurfb.2026.115798_bib22","article-title":"Diverse drug delivery systems for the enhancement of cancer immunotherapy: an overview","volume":"15","author":"Liu","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.colsurfb.2026.115798_bib23","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.jconrel.2021.11.028","article-title":"Nanomaterials targeting tumor associated macrophages for cancer immunotherapy","volume":"341","author":"Zhao","year":"2022","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.colsurfb.2026.115798_bib24","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/s13045-021-01198-9","article-title":"Dysregulated tumor-associated macrophages in carcinogenesis, progression and targeted therapy of gynecological and breast cancers","volume":"14","author":"Xu","year":"2021","journal-title":"J. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.colsurfb.2026.115798_bib25","doi-asserted-by":"crossref","first-page":"162","DOI":"10.4143\/crt.2023.330","article-title":"Tumor microenvironment can predict chemotherapy response of patients with triple-negative breast cancer receiving neoadjuvant chemotherapy","volume":"56","author":"Kim","year":"2023","journal-title":"Cancer Res. Treat."},{"issue":"2","key":"10.1016\/j.colsurfb.2026.115798_bib26","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3892\/ijo.2023.5599","article-title":"Research progress on the role of tumor-associated macrophages in tumor development and their use as molecular targets","volume":"64","author":"Lu","year":"2023","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.colsurfb.2026.115798_bib27","article-title":"Mechanisms of tumor-associated macrophages in breast cancer and treatment strategy","volume":"16","author":"Jin","year":"2025","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.colsurfb.2026.115798_bib28","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s13046-025-03377-9","article-title":"Tumor-associated macrophages remodel the suppressive tumor immune microenvironment and targeted therapy for immunotherapy","volume":"44","author":"Yang","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.colsurfb.2026.115798_bib29","article-title":"Roles of tumor-associated macrophages in triple-negative breast cancer progression","volume":"16","author":"Wu","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.colsurfb.2026.115798_bib30","doi-asserted-by":"crossref","first-page":"757","DOI":"10.3389\/fimmu.2019.00757","article-title":"Tumor-stroma-inflammation networks promote pro-metastatic chemokines and aggressiveness characteristics in triple-negative breast cancer","volume":"10","author":"Liubomirski","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.colsurfb.2026.115798_bib31","article-title":"Metabolic reprogramming induces macrophage polarization in the tumor microenvironment","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.colsurfb.2026.115798_bib32","article-title":"Tumor-associated macrophages: key players in triple-negative breast cancer","volume":"12","author":"Qiu","year":"2022","journal-title":"Front. Oncol."},{"issue":"8","key":"10.1016\/j.colsurfb.2026.115798_bib33","doi-asserted-by":"crossref","first-page":"e0273044","DOI":"10.1371\/journal.pone.0273044","article-title":"Triple-negative breast cancer influences a mixed M1\/M2 macrophage phenotype associated with tumor aggressiveness","volume":"17","author":"Pe","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.colsurfb.2026.115798_bib34","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.3389\/fimmu.2020.01731","article-title":"Redefining tumor-associated macrophage subpopulations and functions in the tumor microenvironment","volume":"11","author":"Wu","year":"2020","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.colsurfb.2026.115798_bib35","doi-asserted-by":"crossref","first-page":"505","DOI":"10.3390\/pharmaceutics14030505","article-title":"Nanomedicine as a promising tool to overcome immune escape in breast cancer","volume":"14","author":"Navarro-Ocon","year":"2022","journal-title":"Pharmaceutics"},{"issue":"8","key":"10.1016\/j.colsurfb.2026.115798_bib36","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1038\/s41590-022-01267-2","article-title":"The complex role of tumor-infiltrating macrophages","volume":"23","author":"Christofides","year":"2022","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.colsurfb.2026.115798_bib37","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12929-019-0568-z","article-title":"Tumor-associated macrophages: an accomplice in solid tumor progression","volume":"26","author":"Y","year":"2019","journal-title":"J. Biomed. Sci."},{"issue":"1","key":"10.1016\/j.colsurfb.2026.115798_bib38","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/s13046-018-0860-x","article-title":"Anti-inflammatory signaling by mammary tumor cells mediates prometastatic macrophage polarization in an innovative intraductal mouse model for triple-negative breast cancer","volume":"37","author":"Steenbrugge","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.colsurfb.2026.115798_bib39","doi-asserted-by":"crossref","DOI":"10.1038\/npjbcancer.2015.25","article-title":"Tumor-associated macrophages: unwitting accomplices in breast cancer malignancy","volume":"2","author":"Williams","year":"2016","journal-title":"NPJ Breast Cancer"},{"issue":"3","key":"10.1016\/j.colsurfb.2026.115798_bib40","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1158\/0008-5472.CAN-20-1414","article-title":"Folate receptor beta designates immunosuppressive tumor-associated myeloid cells that can be reprogrammed with folate-targeted drugs","volume":"81","author":"Cresswell","year":"2021","journal-title":"Cancer Res"},{"issue":"10","key":"10.1016\/j.colsurfb.2026.115798_bib41","doi-asserted-by":"crossref","first-page":"11049","DOI":"10.1002\/cam4.5489","article-title":"Antitumor therapy for breast cancer: focus on tumor-associated macrophages and nanosized drug delivery systems","volume":"12","author":"Zhan","year":"2023","journal-title":"Cancer Med"},{"issue":"1","key":"10.1016\/j.colsurfb.2026.115798_bib42","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s10549-022-06859-y","article-title":"Assessing the role of tumour-associated macrophage subsets in breast cancer subtypes using digital image analysis","volume":"198","author":"Zwager","year":"2023","journal-title":"Breast Cancer Res. Treat."},{"issue":"1","key":"10.1016\/j.colsurfb.2026.115798_bib43","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/s42003-023-04525-7","article-title":"Tissue-resident macrophages are major tumor-associated macrophage resources, contributing to early TNBC development, recurrence, and metastases","volume":"6","author":"Hirano","year":"2023","journal-title":"Commun. Biol."},{"issue":"19","key":"10.1016\/j.colsurfb.2026.115798_bib44","doi-asserted-by":"crossref","first-page":"4829","DOI":"10.3390\/cancers14194829","article-title":"Association of CD206 protein expression with immune infiltration and prognosis in patients with triple-negative breast cancer","volume":"14","author":"Bobrie","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.colsurfb.2026.115798_bib45","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jss.2017.09.035","article-title":"Tumor-associated macrophages correlate with phenomenon of epithelial-mesenchymal transition and contribute to poor prognosis in triple-negative breast cancer patients","volume":"222","author":"Zhang","year":"2018","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.colsurfb.2026.115798_bib46","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ctrv.2018.08.010","article-title":"Tumor-associated macrophages in breast cancer: Innocent bystander or important player?","volume":"70","author":"Qiu","year":"2018","journal-title":"Cancer Treat. Rev."},{"issue":"2","key":"10.1016\/j.colsurfb.2026.115798_bib47","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/modpathol.2017.126","article-title":"Composite analysis of immunological and metabolic markers defines novel subtypes of triple negative breast cancer","volume":"31","author":"Adams","year":"2018","journal-title":"Mod. Pathol."},{"issue":"1","key":"10.1016\/j.colsurfb.2026.115798_bib48","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s13045-023-01494-6","article-title":"Advances in single-cell RNA sequencing and its applications in cancer research","volume":"16","author":"Huang","year":"2023","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.colsurfb.2026.115798_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.neo.2025.101260","article-title":"Multi-omics analysis unveils tumor heterogeneity and immunotherapy predictive model in breast cancer for precision medicine and early detection","volume":"71","author":"Zhao","year":"2026","journal-title":"Neoplasia"},{"issue":"1","key":"10.1016\/j.colsurfb.2026.115798_bib50","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1186\/s12951-025-03321-1","article-title":"Macrophage-derived exosomes in cancer: a double-edged sword with therapeutic potential","volume":"23","author":"Liu","year":"2025","journal-title":"J. Nanobiotechnol."},{"issue":"1","key":"10.1016\/j.colsurfb.2026.115798_bib51","doi-asserted-by":"crossref","DOI":"10.1093\/jleuko\/qiaf176","article-title":"Single-cell analysis identifies inflammatory and tissue remodeling tumor-associated macrophages distinct from M1\/M2 paradigm","volume":"118","author":"L\u00f3pez-Huerta","year":"2026","journal-title":"J. Leukoc. Biol."},{"issue":"7","key":"10.1016\/j.colsurfb.2026.115798_bib52","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.cell.2022.02.021","article-title":"Tissue-resident FOLR2+ macrophages associate with CD8+ T cell infiltration in human breast cancer","volume":"185","author":"Ramos","year":"2022","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.colsurfb.2026.115798_bib53","doi-asserted-by":"crossref","first-page":"5694","DOI":"10.1038\/s41467-024-49916-4","article-title":"Single-cell resolution characterization of myeloid-derived cell states with implication in cancer outcome","volume":"15","author":"Guimar\u00e3es","year":"2024","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.colsurfb.2026.115798_bib54","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/s41698-025-01152-9","article-title":"TREM2-mediated regulation of myeloid cells in the tumor microenvironment: new insights and therapeutic prospects","volume":"9","author":"Huang","year":"2025","journal-title":"npj Precis. Oncol."},{"key":"10.1016\/j.colsurfb.2026.115798_bib55","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1295257","article-title":"Tumor-associated macrophages: an effective player of the tumor microenvironment","volume":"14","author":"Basak","year":"2023","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.colsurfb.2026.115798_bib56","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1158\/0008-5472.CAN-20-2990","article-title":"Macrophage-based approaches for cancer immunotherapy","volume":"81","author":"Anderson","year":"2021","journal-title":"Cancer Res"},{"issue":"6","key":"10.1016\/j.colsurfb.2026.115798_bib57","doi-asserted-by":"crossref","first-page":"3414","DOI":"10.3390\/ijms25063414","article-title":"New strategies for macrophage re-education in cancer: an update","volume":"25","author":"Lampiasi","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.colsurfb.2026.115798_bib58","doi-asserted-by":"crossref","first-page":"828","DOI":"10.3389\/fimmu.2017.00828","article-title":"Reprogramming of tumor-associated macrophages with anticancer therapies: radiotherapy versus chemo-and immunotherapies","volume":"8","author":"Genard","year":"2017","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.colsurfb.2026.115798_bib59","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1021\/acs.bioconjchem.1c00171","article-title":"Bioresorbable Depot for Sustained Release of Immunostimulatory Resiquimod in Suppressing Both Primary Triple-Negative Breast Tumors and Metastatic Occurrence","volume":"32","author":"Xie","year":"2021","journal-title":"Bioconjug. Chem."},{"issue":"46","key":"10.1016\/j.colsurfb.2026.115798_bib60","doi-asserted-by":"crossref","first-page":"53318","DOI":"10.1021\/acsami.3c14137","article-title":"Immunomodulator-mediated suppressive tumor immune microenvironment remodeling nanoplatform for enhanced immuno\/chemo\/photothermal combination therapy of triple negative breast cancer","volume":"15","author":"Wang","year":"2023","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"8","key":"10.1016\/j.colsurfb.2026.115798_bib61","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.3390\/cancers15082366","article-title":"Regression and eradication of triple-negative breast carcinoma in 4T1 mouse model by combination immunotherapies","volume":"15","author":"Nahar","year":"2023","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.colsurfb.2026.115798_bib62","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/s13578-023-01153-w","article-title":"The Streptococcus virulence protein PepO triggers anti-tumor immune responses by reprograming tumor-associated macrophages in a mouse triple negative breast cancer model","volume":"13","author":"Liu","year":"2023","journal-title":"Cell Biosci."},{"issue":"24","key":"10.1016\/j.colsurfb.2026.115798_bib63","doi-asserted-by":"crossref","DOI":"10.1172\/JCI172503","article-title":"Targeting eIF4A triggers an interferon response to synergize with chemotherapy and suppress triple-negative breast cancer","volume":"133","author":"Zhao","year":"2023","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.colsurfb.2026.115798_bib64","article-title":"388 Preliminary results from KEYNOTE-A36, a study of GB1275, a first-in-class oral CD11b modulator, alone and with pembrolizumab or chemotherapy in specified advanced solid tumors","volume":"8","author":"Bendell","year":"2020","journal-title":"J. Immunother. Cancer"},{"issue":"3","key":"10.1016\/j.colsurfb.2026.115798_bib65","article-title":"389 Combining transcriptomic-and tissue-based immune biomarkers to evaluate GB1275, a CD11b modulator, as a single agent or with pembrolizumab in patients with advanced solid tumors","volume":"8","author":"Messersmith","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.colsurfb.2026.115798_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114423","article-title":"HIF-1\u03b1 inhibitor YC-1 suppresses triple-negative breast cancer growth and angiogenesis by targeting PlGF\/VEGFR1-induced macrophage polarization","volume":"161","author":"Li","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.colsurfb.2026.115798_bib67","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s10495-025-02229-3","article-title":"BET bromodomain inhibition potentiates antitumor activity of tumor-associated macrophages and enhances anti-CD47 immunotherapy in triple-negative breast cancer","volume":"31","author":"Mei","year":"2026","journal-title":"Apoptosis"},{"issue":"2","key":"10.1016\/j.colsurfb.2026.115798_bib68","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.ymthe.2025.10.042","article-title":"DCC-2036 induces repolarization of TAMs to M1 type and enhances CD8+ T cell immunity in TNBC","volume":"34","author":"Liang","year":"2026","journal-title":"Mol. Ther."},{"issue":"2","key":"10.1016\/j.colsurfb.2026.115798_bib69","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.antiviral.2004.07.002","article-title":"Resiquimod: a new immune response modifier with potential as a vaccine adjuvant for Th1 immune responses","volume":"64","author":"Wu","year":"2004","journal-title":"Antivir. Res"},{"issue":"12","key":"10.1016\/j.colsurfb.2026.115798_bib70","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1182\/blood-2015-02-630335","article-title":"Topical resiquimod can induce disease regression and enhance T-cell effector functions in cutaneous T-cell lymphoma","volume":"126","author":"Rook","year":"2015","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.colsurfb.2026.115798_bib71","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1093\/jac\/dkt320","article-title":"Liposomal resiquimod for the treatment of Leishmania donovani infection","volume":"69","author":"Peine","year":"2014","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.colsurfb.2026.115798_bib72","doi-asserted-by":"crossref","first-page":"466","DOI":"10.4103\/0378-6323.29352","article-title":"Imiquimod","volume":"72","author":"Jobanputra","year":"2006","journal-title":"Indian J. Dermatol. Venereol. Leprol."},{"key":"10.1016\/j.colsurfb.2026.115798_bib73","series-title":"Imiquimod","author":"Nanda","year":"2023"},{"key":"10.1016\/j.colsurfb.2026.115798_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2024.110226","article-title":"Streptococcus pneumoniae endopeptidase O induces trained immunity and confers protection against various pathogenic infections","volume":"263","author":"Xu","year":"2024","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.colsurfb.2026.115798_bib75","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.766298","article-title":"Zotatifin, an eIF4A-selective inhibitor, blocks tumor growth in receptor tyrosine kinase driven tumors","volume":"11","author":"Gerson-Gurwitz","year":"2021","journal-title":"Front. Oncol."},{"issue":"16","key":"10.1016\/j.colsurfb.2026.115798_bib76","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.1200\/JCO.2022.40.16_suppl.3081","article-title":"First-in-human phase 1\/2 dose escalation and expansion study evaluating first-in-class eIF4A inhibitor zotatifin in patients with solid tumors","volume":"40","author":"Meric-Bernstam","year":"2022","journal-title":"J. Clin. Oncol."},{"issue":"8","key":"10.1016\/j.colsurfb.2026.115798_bib77","doi-asserted-by":"crossref","first-page":"e003005","DOI":"10.1136\/jitc-2021-003005","article-title":"GB1275, a first-in-class CD11b modulator: rationale for immunotherapeutic combinations in solid tumors","volume":"9","author":"DeNardo","year":"2021","journal-title":"J. Immunother. Cancer"},{"issue":"7","key":"10.1016\/j.colsurfb.2026.115798_bib78","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1093\/jnci\/95.7.516","article-title":"YC-1: a potential anticancer drug targeting hypoxia-inducible factor 1","volume":"95","author":"Yeo","year":"2003","journal-title":"J. Natl. Cancer Inst."},{"issue":"1","key":"10.1016\/j.colsurfb.2026.115798_bib79","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2004.01.005","article-title":"Versatile pharmacological actions of YC-1: anti-platelet to anticancer","volume":"207","author":"Chun","year":"2004","journal-title":"Cancer Lett."},{"issue":"3","key":"10.1016\/j.colsurfb.2026.115798_bib80","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41389-020-0218-z","article-title":"BET protein inhibitor JQ1 downregulates chromatin accessibility and suppresses metastasis of gastric cancer via inactivating RUNX2\/NID1 signaling","volume":"9","author":"Zhou","year":"2020","journal-title":"Oncogenesis"},{"key":"10.1016\/j.colsurfb.2026.115798_bib81","first-page":"1021","article-title":"General mechanism of JQ1 in inhibiting various types of cancer","author":"Jiang","year":"2020","journal-title":"Mol. Med. Rep."},{"issue":"1","key":"10.1016\/j.colsurfb.2026.115798_bib82","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41419-024-07263-8","article-title":"Enhancing immunotherapy efficacy in colorectal cancer: targeting the FGR-AKT-SP1-DKK1 axis with DCC-2036 (Rebastinib)","volume":"16","author":"Chen","year":"2025","journal-title":"Cell Death Dis."},{"issue":"3","key":"10.1016\/j.colsurfb.2026.115798_bib83","doi-asserted-by":"crossref","first-page":"519","DOI":"10.3324\/haematol.2016.152710","article-title":"Phase 1 dose-finding study of rebastinib (DCC-2036) in patients with relapsed chronic myeloid leukemia and acute myeloid leukemia","volume":"102","author":"Cortes","year":"2017","journal-title":"Haematologica"},{"key":"10.1016\/j.colsurfb.2026.115798_bib84","article-title":"Triple-negative breast cancer treatment meets nanoparticles: Current status and future direction","volume":"71","author":"Shokooh","year":"2022","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.colsurfb.2026.115798_bib85","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.biopha.2018.11.122","article-title":"Nanosoldiers: A promising strategy to combat triple negative breast cancer","volume":"110","author":"Pawar","year":"2019","journal-title":"Biomed. Pharmacother."},{"issue":"10","key":"10.1016\/j.colsurfb.2026.115798_bib86","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202002163","article-title":"Nanotechnology-based strategies to evaluate and counteract cancer metastasis and neoangiogenesis","volume":"10","author":"\u015een","year":"2021","journal-title":"Adv. Healthc. Mater."},{"issue":"1","key":"10.1016\/j.colsurfb.2026.115798_bib87","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s13346-023-01405-9","article-title":"Drug delivery methods for cancer immunotherapy","volume":"14","author":"P\u00e9rez-Herrero","year":"2024","journal-title":"Drug Deliv. Transl. Res."},{"issue":"10","key":"10.1016\/j.colsurfb.2026.115798_bib88","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.3390\/pharmaceutics13101670","article-title":"Functionalized nanoparticles targeting tumor-associated macrophages as cancer therapy","volume":"13","author":"He","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.colsurfb.2026.115798_bib89","first-page":"13993","article-title":"Impact of nanoparticle physicochemical properties on protein corona and macrophage polarization","author":"Xiao","year":"2023","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"9","key":"10.1016\/j.colsurfb.2026.115798_bib90","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1021\/acsmacrolett.6b00419","article-title":"Shape effect of glyco-nanoparticles on macrophage cellular uptake and immune response","volume":"5","author":"Li","year":"2016","journal-title":"ACS Macro Lett."},{"issue":"32","key":"10.1016\/j.colsurfb.2026.115798_bib91","doi-asserted-by":"crossref","first-page":"21221","DOI":"10.1021\/acsnano.4c04614","article-title":"Nano-mechanical immunoengineering: nanoparticle elasticity reprograms tumor-associated macrophages via piezo1","volume":"18","author":"Yang","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.colsurfb.2026.115798_bib92","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.114019","article-title":"The impact of peptide surface density on PD-L1 receptor inhibition as a therapeutic strategy for triple negative breast cancer","volume":"385","author":"Keshishian","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.colsurfb.2026.115798_bib93","doi-asserted-by":"crossref","first-page":"571","DOI":"10.2147\/IJN.S442877","article-title":"Biomimetic nano-drug delivery system: an emerging platform for promoting tumor treatment","author":"Han","year":"2024","journal-title":"Int. J. Nanomed."},{"issue":"1","key":"10.1016\/j.colsurfb.2026.115798_bib94","doi-asserted-by":"crossref","DOI":"10.1002\/wnan.1913","article-title":"Ultrasound-mediated nano-sized drug delivery systems for cancer treatment: Multi-scale and multi-physics computational modeling","volume":"16","author":"Moradi Kashkooli","year":"2024","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"issue":"1","key":"10.1016\/j.colsurfb.2026.115798_bib95","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s12951-025-03169-5","article-title":"Unveiling the new chapter in nanobody engineering: advances in traditional construction and AI-driven optimization","volume":"23","author":"Liu","year":"2025","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.colsurfb.2026.115798_bib96","article-title":"Cell-derived nanovesicles prepared by membrane extrusion are good substitutes for natural extracellular vesicles","volume":"1","author":"Wen","year":"2022","journal-title":"Extra Vesicle"},{"issue":"1","key":"10.1016\/j.colsurfb.2026.115798_bib97","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-14725-x","article-title":"Bioinspired cell-derived nanovesicles versus exosomes as drug delivery systems: a cost-effective alternative","volume":"7","author":"Goh","year":"2017","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.colsurfb.2026.115798_bib98","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1186\/s12951-022-01416-7","article-title":"All-in-one approaches for triple-negative breast cancer therapy: metal-phenolic nanoplatform for MR imaging-guided combinational therapy","volume":"20","author":"Xie","year":"2022","journal-title":"J. Nanobiotechnol."},{"issue":"3","key":"10.1016\/j.colsurfb.2026.115798_bib99","doi-asserted-by":"crossref","first-page":"511","DOI":"10.3390\/molecules31030511","article-title":"Targeting Triple-Negative Breast Cancer: A Special Focus on Phototherapy and Nanomaterials","volume":"31","author":"Pereira","year":"2026","journal-title":"Molecules"},{"key":"10.1016\/j.colsurfb.2026.115798_bib100","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2020.101024","article-title":"Oxygen-independent free radical generation mediated by core-shell magnetic nanocomposites synergizes with immune checkpoint blockade for effective primary and metastatic tumor treatment","volume":"36","author":"Guo","year":"2021","journal-title":"Nano Today"},{"issue":"10","key":"10.1016\/j.colsurfb.2026.115798_bib101","doi-asserted-by":"crossref","first-page":"4231","DOI":"10.1021\/acs.nanolett.1c00209","article-title":"Polarization of tumor-associated macrophages by nanoparticle-loaded Escherichia coli combined with immunogenic cell death for cancer immunotherapy","volume":"21","author":"Wei","year":"2021","journal-title":"Nano Lett."},{"key":"10.1016\/j.colsurfb.2026.115798_bib102","first-page":"560","article-title":"Tellurium-driven maple leaf-shaped manganese nanotherapeutics reshape tumor microenvironment via chemical transition in situ to achieve highly efficient radioimmunotherapy of triple negative breast cancer","volume":"27","author":"Huang","year":"2023","journal-title":"Bioact. Mater."},{"issue":"2","key":"10.1016\/j.colsurfb.2026.115798_bib103","first-page":"472","article-title":"A targeting black phosphorus nanoparticle based immune cells nano-regulator for photodynamic\/photothermal and photo-immunotherapy","volume":"6","author":"Zhang","year":"2021","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.colsurfb.2026.115798_bib104","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.jconrel.2020.10.001","article-title":"Photoimmunotherapy with cetuximab-conjugated gold nanorods reduces drug resistance in triple negative breast cancer spheroids with enhanced infiltration of tumor-associated macrophages","volume":"329","author":"Emami","year":"2021","journal-title":"J. Control. Release"},{"issue":"6","key":"10.1016\/j.colsurfb.2026.115798_bib105","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1002\/jcb.20796","article-title":"Engineered nanoparticles as precise drug delivery systems","volume":"97","author":"Yih","year":"2006","journal-title":"J. Cell. Biochem."},{"issue":"3","key":"10.1016\/j.colsurfb.2026.115798_bib106","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1007\/s11481-006-9032-4","article-title":"Nanotechnology: a focus on nanoparticles as a drug delivery system","volume":"1","author":"Kingsley","year":"2006","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.colsurfb.2026.115798_bib107","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1614640","article-title":"Modulation of the immune microenvironment using nanomaterials: A new strategy for tumor immunotherapy","volume":"16","author":"Piao","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.colsurfb.2026.115798_bib108","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113789","article-title":"Hypoxia-responsive albumin nanoparticles co-delivering banoxantrone and STING agonist enhance immunotherapy of high-intensity focused ultrasound","author":"Huang","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.colsurfb.2026.115798_bib109","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.actbio.2020.09.038","article-title":"Peptide-guided resiquimod-loaded lignin nanoparticles convert tumor-associated macrophages from M2 to M1 phenotype for enhanced chemotherapy","volume":"133","author":"Figueiredo","year":"2021","journal-title":"Acta Biomater."},{"issue":"15","key":"10.1016\/j.colsurfb.2026.115798_bib110","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1039\/C9TB00089E","article-title":"Photothermally activatable PDA immune nanomedicine combined with PD-L1 checkpoint blockade for antimetastatic cancer photoimmunotherapy","volume":"7","author":"Lu","year":"2019","journal-title":"J. Mater. Chem. B."},{"issue":"2","key":"10.1016\/j.colsurfb.2026.115798_bib111","doi-asserted-by":"crossref","first-page":"3417","DOI":"10.1021\/acsnano.2c00462","article-title":"Nano-ultrasonic contrast agent for chemoimmunotherapy of breast cancer by immune metabolism reprogramming and tumor autophagy","volume":"16","author":"Yang","year":"2022","journal-title":"ACS Nano"},{"key":"10.1016\/j.colsurfb.2026.115798_bib112","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.126912","article-title":"Efficient TNBC immunotherapy by dual reprogramming tumor-infiltrating dendritic cells and tumor-associated macrophages with stimulus-responsive miR155 nanocomplexes","volume":"253","author":"Jing","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.colsurfb.2026.115798_bib113","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.biomaterials.2018.09.017","article-title":"Combination antitumor immunotherapy with VEGF and PIGF siRNA via systemic delivery of multi-functionalized nanoparticles to tumor-associated macrophages and breast cancer cells","volume":"185","author":"Song","year":"2018","journal-title":"Biomater"},{"issue":"1","key":"10.1016\/j.colsurfb.2026.115798_bib114","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s10565-025-10001-1","article-title":"Targeted nanoparticle delivery system for tumor-associated macrophage reprogramming to enhance TNBC therapy","volume":"41","author":"Dong","year":"2025","journal-title":"Cell Biol. Toxicol."},{"key":"10.1016\/j.colsurfb.2026.115798_bib115","article-title":"Application of lipid-based nanoparticles in cancer immunotherapy","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Immunol."},{"issue":"26","key":"10.1016\/j.colsurfb.2026.115798_bib116","doi-asserted-by":"crossref","first-page":"23491","DOI":"10.1021\/acsnano.5c04836","article-title":"Nanomedicine and Spleen-Targeting Strategies for Precision Immunomodulation: Advances, Challenges, and Future Perspectives","volume":"19","author":"Oh","year":"2025","journal-title":"ACS Nano"},{"issue":"51","key":"10.1016\/j.colsurfb.2026.115798_bib117","article-title":"CSF1R-and SHP2-inhibitor-loaded nanoparticles enhance cytotoxic activity and phagocytosis in tumor-associated macrophages","volume":"31","author":"Ramesh","year":"2019","journal-title":"Adv. Mater."},{"issue":"9","key":"10.1016\/j.colsurfb.2026.115798_bib118","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202106296","article-title":"Fibroblast activation protein-\u03b1 responsive peptide assembling prodrug nanoparticles for remodeling the immunosuppressive microenvironment and boosting cancer immunotherapy","volume":"18","author":"Sun","year":"2022","journal-title":"Small"},{"key":"10.1016\/j.colsurfb.2026.115798_bib119","doi-asserted-by":"crossref","DOI":"10.34133\/bmr.0086","article-title":"Inorganic nanoparticle functionalization strategies in immunotherapeutic applications","volume":"28","author":"Mao","year":"2024","journal-title":"Biomater. Res."},{"key":"10.1016\/j.colsurfb.2026.115798_bib120","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2025.125333","article-title":"Harnessing the power of inorganic nanoparticles for the management of TNBC","volume":"672","author":"Rout","year":"2025","journal-title":"Int. J. Pharm."},{"issue":"12","key":"10.1016\/j.colsurfb.2026.115798_bib121","doi-asserted-by":"crossref","first-page":"20400","DOI":"10.1021\/acsnano.2c06646","article-title":"Tumor microenvironment-activable manganese-boosted catalytic immunotherapy combined with PD-1 checkpoint blockade","volume":"16","author":"Zhao","year":"2022","journal-title":"ACS Nano"},{"key":"10.1016\/j.colsurfb.2026.115798_bib122","first-page":"42724","article-title":"Polarization Engineering and Chemical Bond Reconstruction in Rare-Earth Hexagonal Manganite via Fe3+-Occupied B-Site Doping for Piezocatalytic Therapy and Ferroptosis","author":"Yang","year":"2025","journal-title":"J. Am. Chem. Soc."},{"issue":"30","key":"10.1016\/j.colsurfb.2026.115798_bib123","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202419673","article-title":"Engineered nanozymes with asymmetric Mn-O-Ce sites for intratumorally leveraged multimode therapy","volume":"37","author":"Ye","year":"2025","journal-title":"Adv. Mater."},{"issue":"45","key":"10.1016\/j.colsurfb.2026.115798_bib124","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202512426","article-title":"Self-Doped Cu2+ xZn1-xSnSe4 Nanosheets for Enhanced Thermoelectric Catalytic-Ferroptotic Therapy","volume":"37","author":"Zhang","year":"2025","journal-title":"Adv. Mater."},{"issue":"7","key":"10.1016\/j.colsurfb.2026.115798_bib125","doi-asserted-by":"crossref","first-page":"10904","DOI":"10.1021\/acsnano.2c03222","article-title":"Dual glutathione depletion enhanced enzyme catalytic activity for hyperthermia assisted tumor therapy on semi-metallic VSe2\/Mn-CS","volume":"16","author":"Zhao","year":"2022","journal-title":"ACS Nano"},{"issue":"24","key":"10.1016\/j.colsurfb.2026.115798_bib126","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202420540","article-title":"Dual-Release Free Iron and Breakdown of Ferroptosis Defenses to Achieve Ferroptosis Cascade Storms for Potent Antitumor Therapy","volume":"35","author":"Xu","year":"2025","journal-title":"Adv. Funct. Mater."},{"issue":"33","key":"10.1016\/j.colsurfb.2026.115798_bib127","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202501642","article-title":"Dual strategy of Ca2+ influx and collagen denaturation to remodel the extracellular matrix and amplify sonopiezoelectric therapy","volume":"37","author":"Yu","year":"2025","journal-title":"Adv. Mater."},{"issue":"13","key":"10.1016\/j.colsurfb.2026.115798_bib128","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202308747","article-title":"Spark\u201d PtMnIr nanozymes for electrodynamic-boosted multienzymatic tumor immunotherapy","volume":"36","author":"Li","year":"2024","journal-title":"Adv. Mater."},{"issue":"45","key":"10.1016\/j.colsurfb.2026.115798_bib129","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202510010","article-title":"Tumor Microenvironment-Activated Fe3+-Doped Dendritic Mesoporous Organosilica Nanocomposites as Ferroptosis Inducers for Enhanced Immunotherapy","volume":"37","author":"Feng","year":"2025","journal-title":"Adv. Mater."},{"issue":"19","key":"10.1016\/j.colsurfb.2026.115798_bib130","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202417198","article-title":"Hetero-Trimetallic Atom Catalysts Enable Targeted ROS Generation and Redox Signaling for Intensive Apoptosis and Ferroptosis","volume":"37","author":"Li","year":"2025","journal-title":"Adv. Mater."},{"issue":"24","key":"10.1016\/j.colsurfb.2026.115798_bib131","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202400416","article-title":"Phase engineered CuxS-Ag2S with photothermoelectric activity for enhanced multienzyme activity and dynamic therapy","volume":"36","author":"Zang","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.colsurfb.2026.115798_bib132","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.120739","article-title":"Blue light-triggered Fe2+-release from monodispersed ferrihydrite nanoparticles for cancer iron therapy","volume":"271","author":"Yang","year":"2021","journal-title":"Biomater"},{"issue":"15","key":"10.1016\/j.colsurfb.2026.115798_bib133","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201807211","article-title":"Artificially reprogrammed macrophages as tumor-tropic immunosuppression-resistant biologics to realize therapeutics production and immune activation","volume":"31","author":"Li","year":"2019","journal-title":"Adv. Mater."},{"issue":"38","key":"10.1016\/j.colsurfb.2026.115798_bib134","doi-asserted-by":"crossref","first-page":"5861","DOI":"10.1039\/C9TB01250H","article-title":"Hyaluronic acid modified doxorubicin loaded Fe3O4 nanoparticles effectively inhibit breast cancer metastasis","volume":"7","author":"Gong","year":"2019","journal-title":"J. Mater. Chem. B."},{"issue":"2","key":"10.1016\/j.colsurfb.2026.115798_bib135","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1021\/acs.nanolett.9b02916","article-title":"Metal-organic framework nanoparticles for ameliorating breast cancer-associated osteolysis","volume":"20","author":"Pang","year":"2020","journal-title":"Nano Lett."},{"issue":"1","key":"10.1016\/j.colsurfb.2026.115798_bib136","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1039\/C9NR06505A","article-title":"Polarization of tumor-associated macrophage phenotype via porous hollow iron nanoparticles for tumor immunotherapy in vivo","volume":"12","author":"Li","year":"2020","journal-title":"Nanoscale"},{"issue":"1","key":"10.1016\/j.colsurfb.2026.115798_bib137","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1186\/s12951-023-02122-8","article-title":"Targeting and repolarizing M2-like tumor-associated macrophage-mediated MR imaging and tumor immunotherapy by biomimetic nanoparticles","volume":"21","author":"Chong","year":"2023","journal-title":"J. Nanobiotechnol."},{"issue":"19","key":"10.1016\/j.colsurfb.2026.115798_bib138","doi-asserted-by":"crossref","first-page":"6403","DOI":"10.1039\/D1BM00675D","article-title":"Enhanced anti-tumor efficacy by inhibiting HIF-1\u03b1 to reprogram TAMs via core-satellite upconverting nanoparticles with curcumin mediated photodynamic therapy","volume":"9","author":"Zhang","year":"2021","journal-title":"Biomater. Sci."},{"issue":"12","key":"10.1016\/j.colsurfb.2026.115798_bib139","doi-asserted-by":"crossref","first-page":"3580","DOI":"10.7150\/thno.33141","article-title":"An in situ microenvironmental nano-regulator to inhibit the proliferation and metastasis of 4T1 tumor","volume":"9","author":"Zhang","year":"2019","journal-title":"Theranostics"},{"issue":"10","key":"10.1016\/j.colsurfb.2026.115798_bib140","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1039\/D5BM00189G","article-title":"MnO2-based nanoparticles remodeling tumor micro-environment to augment sonodynamic immunotherapy against breast cancer","volume":"13","author":"Liao","year":"2025","journal-title":"Biomater. Sci."},{"issue":"11","key":"10.1016\/j.colsurfb.2026.115798_bib141","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202108908","article-title":"Reshaping the tumor immune microenvironment based on a light-activated nanoplatform for efficient cancer therapy","volume":"34","author":"Yang","year":"2022","journal-title":"Adv. Mater."},{"key":"10.1016\/j.colsurfb.2026.115798_bib142","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2019.119515","article-title":"Iron chelated melanin-like nanoparticles for tumor-associated macrophage repolarization and cancer therapy","volume":"225","author":"Rong","year":"2019","journal-title":"Biomater"},{"issue":"10","key":"10.1016\/j.colsurfb.2026.115798_bib143","doi-asserted-by":"crossref","first-page":"14164","DOI":"10.1021\/acsnano.0c07071","article-title":"Engineering of cascade-responsive nanoplatform to inhibit lactate efflux for enhanced tumor chemo-immunotherapy","volume":"14","author":"Li","year":"2020","journal-title":"ACS Nano"},{"issue":"6","key":"10.1016\/j.colsurfb.2026.115798_bib144","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1021\/acsmaterialslett.5c00170","article-title":"Magnetic Persistent Luminescence Nanoparticles Repolarize Tumor-Associated Macrophages for Enhanced Cancer Immunotherapy","volume":"7","author":"Wang","year":"2025","journal-title":"ACS Mater. Lett."},{"issue":"47","key":"10.1016\/j.colsurfb.2026.115798_bib145","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202004853","article-title":"Activating macrophage-mediated cancer immunotherapy by genetically edited nanoparticles","volume":"32","author":"Rao","year":"2020","journal-title":"Adv. Mater."},{"issue":"38","key":"10.1016\/j.colsurfb.2026.115798_bib146","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202003543","article-title":"A biomimetic polymer magnetic nanocarrier polarizing tumor-associated macrophages for potentiating immunotherapy","volume":"16","author":"Liu","year":"2020","journal-title":"Small"},{"key":"10.1016\/j.colsurfb.2026.115798_bib147","article-title":"A \u2018two-missile\u2019 nanoplatform for targeting triple-negative breast cancer: prodrug activation and immune enhancement","volume":"32","author":"Hu","year":"2025","journal-title":"Mater. Today Bio."},{"issue":"19","key":"10.1016\/j.colsurfb.2026.115798_bib148","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201704307","article-title":"Biodistribution, clearance, and long-term fate of clinically relevant nanomaterials","volume":"30","author":"Bourquin","year":"2018","journal-title":"Adv. Mater."},{"key":"10.1016\/j.colsurfb.2026.115798_bib149","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.addr.2019.07.006","article-title":"Subchronic and chronic toxicity evaluation of inorganic nanoparticles for delivery applications","volume":"144","author":"Mohammadpour","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.colsurfb.2026.115798_bib150","article-title":"Challenges and toxicity assessment of inorganic nanomaterials in biomedical applications: Current status and future roadmaps","volume":"87","author":"Mahamuni-Badiger","year":"2023","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"23","key":"10.1016\/j.colsurfb.2026.115798_bib151","doi-asserted-by":"crossref","first-page":"21538","DOI":"10.1021\/acsnano.5c03590","article-title":"Rational design of safer inorganic nanoparticles via mechanistic modeling-informed machine learning","volume":"19","author":"Cave","year":"2025","journal-title":"ACS Nano"},{"issue":"10","key":"10.1016\/j.colsurfb.2026.115798_bib152","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201805730","article-title":"Degradability and clearance of inorganic nanoparticles for biomedical applications","volume":"31","author":"Yang","year":"2019","journal-title":"Adv. Mater."},{"issue":"2","key":"10.1016\/j.colsurfb.2026.115798_bib153","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3390\/pharmaceutics9020012","article-title":"Liposomal formulations in clinical use: an updated review","volume":"9","author":"Bulbake","year":"2017","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.colsurfb.2026.115798_bib154","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2025.126999","article-title":"Nanoparticle-enhanced drug delivery systems: An up-to-date review","author":"Chenxi","year":"2025","journal-title":"J. Mol. Liq."},{"issue":"22","key":"10.1016\/j.colsurfb.2026.115798_bib155","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.120638","article-title":"A nanoparticle-incorporated STING activator enhances antitumor immunity in PD-L1-insensitive models of triple-negative breast cancer","volume":"3","author":"Cheng","year":"2018","journal-title":"JCI Insight"},{"issue":"7","key":"10.1016\/j.colsurfb.2026.115798_bib156","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1021\/acs.biomac.9b00788","article-title":"Two-way cruise nanosatellite promotes metastasis inhibition by immunochemotherapy","volume":"20","author":"Du","year":"2019","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.colsurfb.2026.115798_bib157","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.120639","article-title":"Noninvasively immunogenic sonodynamic therapy with manganese protoporphyrin liposomes against triple-negative breast cancer","volume":"269","author":"Chen","year":"2021","journal-title":"Biomater"},{"issue":"8","key":"10.1016\/j.colsurfb.2026.115798_bib158","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpha.2024.01.009","article-title":"In situ repolarization of tumor-associated macrophages with synergic nanoformulation to reverse immunosuppressive TME in mouse breast cancer for cancer therapy","volume":"14","author":"Luo","year":"2024","journal-title":"J. Pharm. Anal."},{"issue":"14","key":"10.1016\/j.colsurfb.2026.115798_bib159","doi-asserted-by":"crossref","first-page":"6031","DOI":"10.1021\/acs.nanolett.1c01210","article-title":"Detachable liposomes combined immunochemotherapy for enhanced triple-negative breast cancer treatment through reprogramming of tumor-associated macrophages","volume":"21","author":"Chen","year":"2021","journal-title":"Nano Lett."},{"key":"10.1016\/j.colsurfb.2026.115798_bib160","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1093607","article-title":"Exosomes as smart drug delivery vehicles for cancer immunotherapy","volume":"13","author":"Zhang","year":"2023","journal-title":"Front. Immunol."},{"issue":"19","key":"10.1016\/j.colsurfb.2026.115798_bib161","doi-asserted-by":"crossref","first-page":"4879","DOI":"10.3390\/cancers15194879","article-title":"Extracellular vesicles in triple-negative breast cancer: immune regulation, biomarkers, and immunotherapeutic potential","volume":"15","author":"Das","year":"2023","journal-title":"Cancers"},{"issue":"2","key":"10.1016\/j.colsurfb.2026.115798_bib162","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/s41419-024-06494-z","article-title":"Roles of exosomes in immunotherapy for solid cancers","volume":"15","author":"Lyu","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.colsurfb.2026.115798_bib163","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1093607","article-title":"Exosomes as smart drug delivery vehicles for cancer immunotherapy","volume":"13","author":"Zhang","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.colsurfb.2026.115798_bib164","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2020.128217","article-title":"Synergistic ferroptosis and macrophage re-polarization using engineering exosome-mimic M1 nanovesicles for cancer metastasis suppression","volume":"409","author":"Li","year":"2021","journal-title":"Chem. Eng. J."},{"issue":"5","key":"10.1016\/j.colsurfb.2026.115798_bib165","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1002\/anie.201912524","article-title":"Responsive exosome nano-bioconjugates for synergistic cancer therapy","volume":"59","author":"Nie","year":"2020","journal-title":"Angew. Chem. Int. Ed."},{"issue":"7","key":"10.1016\/j.colsurfb.2026.115798_bib166","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202005562","article-title":"Self-activatable photo-extracellular vesicle for synergistic trimodal anticancer therapy","volume":"33","author":"Ding","year":"2021","journal-title":"Adv. Mater."},{"key":"10.1016\/j.colsurfb.2026.115798_bib167","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.jconrel.2023.11.051","article-title":"OX40L-expressing M1-like macrophage exosomes for cancer immunotherapy","volume":"365","author":"Yu","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.colsurfb.2026.115798_bib168","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2021.130579","article-title":"Iron oxide-based enzyme mimic nanocomposite for dual-modality imaging guided chemical phototherapy and anti-tumor immunity against immune cold triple-negative breast cancer","volume":"425","author":"Guan","year":"2021","journal-title":"Chem. Eng. J."},{"issue":"11","key":"10.1016\/j.colsurfb.2026.115798_bib169","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202500003","article-title":"Synchronously Delivering Melittin and Evoking Ferroptosis via Tumor Microenvironment-Triggered Self-Destructive Metal-Organic Frameworks to Boost Cancer Immunotherapy","volume":"14","author":"Zhang","year":"2025","journal-title":"Adv. Healthc. Mater."},{"issue":"48","key":"10.1016\/j.colsurfb.2026.115798_bib170","doi-asserted-by":"crossref","first-page":"14182","DOI":"10.1039\/D3SC02022C","article-title":"An erythrocyte membrane-camouflaged fluorescent covalent organic framework for starving\/nitric oxide\/immunotherapy of triple-negative breast cancer","volume":"14","author":"Yuan","year":"2023","journal-title":"Chem. Sci."},{"issue":"41","key":"10.1016\/j.colsurfb.2026.115798_bib171","doi-asserted-by":"crossref","first-page":"36323","DOI":"10.1021\/acsnano.5c09413","article-title":"Spatiotemporally controlled nanomicelles for synergistic phototherapy and immune reprogramming in triple-negative breast cancer","volume":"19","author":"Chang","year":"2025","journal-title":"ACS Nano"},{"key":"10.1016\/j.colsurfb.2026.115798_bib172","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2023.101884","article-title":"High-dose paclitaxel and its combination with CSF1R inhibitor in polymeric micelles for chemoimmunotherapy of triple negative breast cancer","volume":"51","author":"Lim","year":"2023","journal-title":"Nano Today"},{"key":"10.1016\/j.colsurfb.2026.115798_bib173","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jconrel.2019.09.021","article-title":"Selectively targeting tumor-associated macrophages and tumor cells with polymeric micelles for enhanced cancer chemo-immunotherapy","volume":"313","author":"Wei","year":"2019","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.colsurfb.2026.115798_bib174","doi-asserted-by":"crossref","first-page":"5670","DOI":"10.1038\/s41467-024-49825-6","article-title":"An in-situ peptide-antibody self-assembly to block CD47 and CD24 signaling enhances macrophage-mediated phagocytosis and anti-tumor immune responses","volume":"15","author":"Zhang","year":"2024","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.colsurfb.2026.115798_bib175","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202006189","article-title":"Tumor-associated macrophage and tumor-cell dually transfecting polyplexes for efficient interleukin-12 cancer gene therapy","volume":"33","author":"Qiu","year":"2021","journal-title":"Adv. Mater."},{"issue":"41","key":"10.1016\/j.colsurfb.2026.115798_bib176","doi-asserted-by":"crossref","first-page":"45873","DOI":"10.1021\/acsami.0c14405","article-title":"Tumor microenvironment-triggered charge reversal polymetformin-based nanosystem co-delivered doxorubicin and IL-12 cytokine gene for chemo-gene combination therapy on metastatic breast cancer","volume":"12","author":"Sun","year":"2020","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.colsurfb.2026.115798_bib177","doi-asserted-by":"crossref","DOI":"10.1016\/j.mtbio.2025.102012","article-title":"Biomimetic tumor cell membrane-camouflaged nanomicelles for synergistic chemo-immunotherapy of triple-negative breast cancer","author":"Xu","year":"2025","journal-title":"Mater. Today Bio."},{"issue":"5","key":"10.1016\/j.colsurfb.2026.115798_bib178","doi-asserted-by":"crossref","first-page":"4667","DOI":"10.1021\/acsnano.2c10893","article-title":"Oxygen self-generating nanoreactor mediated ferroptosis activation and immunotherapy in triple-negative breast cancer","volume":"17","author":"Li","year":"2023","journal-title":"ACS Nano"},{"issue":"42","key":"10.1016\/j.colsurfb.2026.115798_bib179","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201903242","article-title":"A designer scaffold with immune nanoconverters for reverting immunosuppression and enhancing immune checkpoint blockade therapy","volume":"31","author":"Phuengkham","year":"2019","journal-title":"Adv. Mater."},{"issue":"14","key":"10.1016\/j.colsurfb.2026.115798_bib180","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202208059","article-title":"X-ray-guided in situ genetic engineering of macrophages for sustained cancer immunotherapy","volume":"35","author":"Zhao","year":"2023","journal-title":"Adv. Mater."},{"issue":"24","key":"10.1016\/j.colsurfb.2026.115798_bib181","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202211332","article-title":"Reprogramming hypoxic tumor-associated macrophages by nanoglycoclusters for boosted cancer immunotherapy","volume":"35","author":"Zhao","year":"2023","journal-title":"Adv. Mater."},{"issue":"26","key":"10.1016\/j.colsurfb.2026.115798_bib182","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adf2746","article-title":"A localized hydrogel-mediated chemotherapy causes immunogenic cell death via activation of ceramide-mediated unfolded protein response","volume":"9","author":"Kar","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.colsurfb.2026.115798_bib183","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2025.123390","article-title":"Innovative DNA tetrahedron inspired by ancient mortise-and-tenon technique offers new immunotherapy strategy for metastatic breast cancer","volume":"322","author":"Zhang","year":"2025","journal-title":"Biomater"},{"issue":"12","key":"10.1016\/j.colsurfb.2026.115798_bib184","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1038\/s41565-021-00988-z","article-title":"A lysosome-targeted DNA nanodevice selectively targets macrophages to attenuate tumours","volume":"16","author":"Cui","year":"2021","journal-title":"Nat. Nanotechnol."},{"issue":"34","key":"10.1016\/j.colsurfb.2026.115798_bib185","doi-asserted-by":"crossref","first-page":"31077","DOI":"10.1021\/acsnano.5c09460","article-title":"Reprogramming macrophage via an antigen phagocytosis-presentation nanoenhancer for improved cancer immunotherapy","volume":"19","author":"Liu","year":"2025","journal-title":"ACS Nano"},{"issue":"4","key":"10.1016\/j.colsurfb.2026.115798_bib186","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/s41416-024-02715-6","article-title":"Clinical landscape of macrophage-reprogramming cancer immunotherapies","volume":"131","author":"Rannikko","year":"2024","journal-title":"Br. J. Cancer"},{"issue":"7","key":"10.1016\/j.colsurfb.2026.115798_bib187","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1001\/jamaoncol.2016.6007","article-title":"Topical imiquimod plus nab-paclitaxel for breast cancer cutaneous metastases: a phase 2 clinical trial","volume":"3","author":"Salazar","year":"2017","journal-title":"JAMA Oncol."},{"issue":"4","key":"10.1016\/j.colsurfb.2026.115798_bib188","doi-asserted-by":"crossref","first-page":"e011173","DOI":"10.1136\/jitc-2024-011173","article-title":"Topical TLR7 agonist and radiotherapy in patients with metastatic breast cancer","volume":"13","author":"Adams","year":"2025","journal-title":"J. Immunother. Cancer"},{"issue":"8","key":"10.1016\/j.colsurfb.2026.115798_bib189","doi-asserted-by":"crossref","first-page":"e009160","DOI":"10.1136\/jitc-2024-009160","article-title":"Eganelisib combined with immune checkpoint inhibitor therapy and chemotherapy in frontline metastatic triple-negative breast cancer triggers macrophage reprogramming, immune activation and extracellular matrix reorganization in the tumor microenvironment","volume":"12","author":"O'Connell","year":"2024","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.colsurfb.2026.115798_bib190","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2025.125202","article-title":"Navigating translational research in nanomedicine: a strategic guide to formulation and manufacturing","volume":"671","author":"Zhang","year":"2025","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.colsurfb.2026.115798_bib191","first-page":"1","article-title":"Smart nanocarriers in triple-negative breast cancer: recent advances in targeting and translational application","author":"Mishra","year":"2025","journal-title":"Drug Deliv. Transl. Res."},{"issue":"1","key":"10.1016\/j.colsurfb.2026.115798_bib192","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/s40364-024-00714-6","article-title":"Tumor microenvironment and immunotherapy for triple-negative breast cancer","volume":"12","author":"Guo","year":"2024","journal-title":"Biomark. Res."},{"key":"10.1016\/j.colsurfb.2026.115798_bib193","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.828810","article-title":"Nanomaterial technology and triple negative breast cancer","volume":"11","author":"Hou","year":"2022","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.colsurfb.2026.115798_bib194","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s10565-025-10001-1","article-title":"Targeted nanoparticle delivery system for tumor-associated macrophage reprogramming to enhance TNBC therapy","volume":"41","author":"Dong","year":"2025","journal-title":"Cell Biol. Toxicol."},{"issue":"11","key":"10.1016\/j.colsurfb.2026.115798_bib195","doi-asserted-by":"crossref","DOI":"10.1002\/cnma.202500389","article-title":"Nanomaterial-based precision medicine for breast cancer diagnosis and treatment","volume":"11","author":"Ndongwe","year":"2025","journal-title":"ChemNanoMat"},{"key":"10.1016\/j.colsurfb.2026.115798_bib196","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115414","article-title":"Subverted macrophages in the triple-negative breast cancer ecosystem","volume":"166","author":"Shang","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.colsurfb.2026.115798_bib197","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2024.102868","article-title":"CAR-T cell therapy for breast cancer: current status and future perspective","volume":"133","author":"Buono","year":"2025","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.colsurfb.2026.115798_bib198","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jconrel.2018.10.008","article-title":"Biomaterials for vaccine-based cancer immunotherapy","volume":"292","author":"Zhang","year":"2018","journal-title":"J. Control. Release"},{"issue":"6","key":"10.1016\/j.colsurfb.2026.115798_bib199","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.7150\/thno.82920","article-title":"The role of lipid metabolic reprogramming in tumor microenvironment","volume":"13","author":"Yang","year":"2023","journal-title":"Theranostics"},{"issue":"12","key":"10.1016\/j.colsurfb.2026.115798_bib200","first-page":"5856","article-title":"Ferroptosis: a promising target for cancer immunotherapy","volume":"11","author":"Sun","year":"2021","journal-title":"Am. J. Cancer Res."},{"issue":"2","key":"10.1016\/j.colsurfb.2026.115798_bib201","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3390\/cells10020303","article-title":"Iron metabolism in the tumor microenvironment\u2014implications for anti-cancer immune response","volume":"10","author":"Sacco","year":"2021","journal-title":"Cells"},{"issue":"17","key":"10.1016\/j.colsurfb.2026.115798_bib202","doi-asserted-by":"crossref","first-page":"4364","DOI":"10.3390\/cancers15174364","article-title":"Applications of CRISPR technology to breast cancer and triple negative breast cancer research","volume":"15","author":"Pont","year":"2023","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.colsurfb.2026.115798_bib203","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10555-025-10275-1","article-title":"CRISPR screening approaches in breast cancer research","volume":"44","author":"Samuels","year":"2025","journal-title":"Cancer Metastas-.-. Rev."},{"issue":"1","key":"10.1016\/j.colsurfb.2026.115798_bib204","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/GCO.0000000000000145","article-title":"Genomic profiling of breast cancers","volume":"27","author":"Curtis","year":"2015","journal-title":"Curr. Opin. Obstet. Gynecol."},{"issue":"15","key":"10.1016\/j.colsurfb.2026.115798_bib205","doi-asserted-by":"crossref","first-page":"7300","DOI":"10.3390\/ijms26157300","article-title":"Genomic predictive biomarkers in breast cancer: the haves and have nots","volume":"26","author":"Beecher","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.colsurfb.2026.115798_bib206","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2025.189369","article-title":"Sequencing of antibody drug conjugates in breast cancer: evidence gap and future directions","author":"Pacholczak-Madej","year":"2025","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"issue":"7","key":"10.1016\/j.colsurfb.2026.115798_bib207","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.3390\/pharmaceutics15071916","article-title":"Artificial intelligence in pharmaceutical technology and drug delivery design","volume":"15","author":"Vora","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.colsurfb.2026.115798_bib208","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2025.102668","article-title":"Geometric-aware deep learning enables discovery of bifunctional ligand-based liposomes for tumor targeting therapy","volume":"61","author":"Xia","year":"2025","journal-title":"Nano Today"}],"container-title":["Colloids and Surfaces B: Biointerfaces"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0927776526003863?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0927776526003863?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T19:15:44Z","timestamp":1785784544000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0927776526003863"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":208,"alternative-id":["S0927776526003863"],"URL":"https:\/\/doi.org\/10.1016\/j.colsurfb.2026.115798","relation":{},"ISSN":["0927-7765"],"issn-type":[{"value":"0927-7765","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Emerging trends in implication of nanocarriers in repolarization of tumor associated macrophages for improved triple negative breast cancer therapy","name":"articletitle","label":"Article Title"},{"value":"Colloids and Surfaces B: Biointerfaces","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.colsurfb.2026.115798","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115798"}}